
ErlySign Raises ₹16 Crore in Pre-Series A Funding to Revolutionize Cancer Diagnostics
Reading Time: < 1 minuteErlySign will use the funds to complete clinical trials, secure CDSCO approvals, launch its oral cancer detection kit, and support R&D, team growth, and patent filings.